MK0826, /Duration of Treatment : 8 Weeks

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Complicated Intra-Abdominal InfectionsIntra-abdominal Infection

Phase 3

Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037)

CompletedNCT00389987

Merck Sharp & Dohme LLCComplicated Intra-Abdominal Infections

Start: 2001-09-30End: 2004-05-31Target: 300Updated: 2017-02-17

A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802)

CompletedNCT00481702

Merck Sharp & Dohme LLCIntra-abdominal Infection

Start: 2001-12-31End: 2003-06-30Target: 300Updated: 2017-02-20